Skip to main content
. 2019 Jan 2;10(3):357–365. doi: 10.3892/mco.2019.1796

Figure 4.

Figure 4.

Comparison of OS between Bev vs. no Bev groups. OS, overall survival; Bev, bevacizumab; HR, hazard ratio; CI, confidence interval.